Drug Information

Drug General Information
Drug ID
D06QYM
Former ID
DIB019429
Drug Name
compound 3
Drug Type
Small molecular drug
Indication Discovery agent Investigative [531359], [541061]
Structure
Download
2D MOL
Formula
C20H24F4N2O3
InChI
InChI=1S/C20H24F4N2O3/c1-20(6-7-20)29-19(28)26-8-4-12(5-9-26)16(23)11-25-17(27)10-13-14(21)2-3-15(22)18(13)24/h2-3,12,16H,4-11H2,1H3,(H,25,27)/t16-/m1/s1
InChIKey
QCIKTRZVLCLGFT-MRXNPFEDSA-N
PubChem Compound ID
51346816
PubChem Substance ID
121264637, 124968176, 125087989, 178102350, 234019027
Target and Pathway
Target(s) Glucose-dependent insulinotropic receptor Target Info Agonist [531359]
KEGG Pathway cAMP signaling pathway
Insulin secretion
WikiPathways Incretin Synthesis, Secretion, and Inactivation
References
Ref 531359Design and evaluation of a 2-(2,3,6-trifluorophenyl)acetamide derivative as an agonist of the GPR119 receptor. Bioorg Med Chem Lett. 2011 Mar 1;21(5):1306-9.
Ref 541061(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5724).
Ref 531359Design and evaluation of a 2-(2,3,6-trifluorophenyl)acetamide derivative as an agonist of the GPR119 receptor. Bioorg Med Chem Lett. 2011 Mar 1;21(5):1306-9.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.